This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Admiral Group | JP Morgan cuts TP to 1022p from 1122p, underweight |
| Balfour Beatty | Numis ups TP to 315p from 285p, add |
| Bunzl | JP Morgan downgrades to neutral from overweight |
| Centrica | HSBC downgrades to neutral from overweight |
| Chemring | JP Morgan downgrades to neutral from overweight |
| Diageo | Investec downgrades to sell from Hold; TP to 1865p from 1900p |
| Drax Group | HSBC cuts TP to 680p from 735p, neutral |
| Glencore Xstrata | Liberum downgrades to Hold |
| IQE | Liberum downgrades to Hold from Buy |
| Johnson Matthey | JP Morgan ups to overweight from neutral; ups TP to 4000p from 2800p |
| O’Key Group | JP Morgan ups to neutral from underweight; ups TP to $13 from $12.50 |
| SABMiller | Nomura cuts TP to 2700p from 2800p, reduce |
| SABMiller | Citigroup downgrades to neutral from Buy; TP to 3200p from 3550p |
| SSE | HSBC cuts TP to 1610p from 1630p, neutral |
| SSE | JP Morgan cuts TP to 1200p from 1220p, underweight |
| Travis Perkins | RBC ups to top pick from outperform, ups TP to 1900p from 1550p |
| X5 Retail | UBS cuts TP to $18.20 from $19.20, neutral |
| X5 Retail | HSBC downgrades to underweight from neutral; cuts TP to $17.5 from $19 |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research